## **Trustees' Annual Report for the period** Period start date 18 11 2022 Period end date 31 03 2024 **From To** ## Section A Reference and administration details GetGenome **Charity name** GetGenome **Other names charity is known by Registered charity number (if any)** 1201069 **Charity's principal address** THE SAINSBURY LABORATORY COLNEY LANE, COLNEY NORWICH **Postcode NR4 7UH** ## **Names of the charity trustees who manage the charity** |1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**
**year**|**Name of person (or body) entitled**
**to appoint trustee (if any)**| |---|---|---|---|---| ||Nicolas Jose
Talbot|||| ||Saskia Adriane
Hogenhout|||| ||Sophien Kamoun|||| ||Appolinaire Djikeng|||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| |||||| ## **Names of the trustees for the charity, if any, (for example, any custodian trustees)** **Name Dates acted if not for whole year** March **2012** **TAR** 1 ## **Names and addresses of advisers (Optional information)** **Type of adviser Name Address** ## **Name of chief executive or names of senior staff members (Optional information)** ## **Section B Structure, governance and management** ## **Description of the charity’s trusts** Type of governing document Constitution - (eg. trust deed, constitution) How the charity is constituted Charitable Incorporated Organisation - (eg. trust, association, company) Trustee selection methods Appointed by existing trustees - (eg. appointed by, elected by) ## **Additional governance issues (Optional information)** You **may choose** to include additional information, where relevant, about: - policies and procedures adopted for the induction and training of trustees; - the charity’s organisational structure and any wider network with which the charity works; - relationship with any related parties; - trustees’ consideration of major risks and the system and procedures to manage them. ## **Section C Objectives and activities** **Summary of the objects of the charity set out in its governing document** The objects of the CIO are to advance science and education through the provision of equitable access to genomics technology and related training for the public benefit (and particularly amongst scientists) in all aspects of that subject. March **2012** **TAR** 2 GetGenome provides support for scientists throughout the global south by providing training in the field of genomics and open science publishing. GetGenome’s empowerment of researchers strengthens local research capabilities and enables advancements in scientific knowledge that contribute to the global public good. GetGenome supports research across a variety of life science fields and has built valuable networks to support researchers’ learning and collaboration potential. **Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** The Trustees have taken due regard to the commission’s public benefit guidance when exercising their powers and duties as set out in the Charities Regulation 2008. During the reporting period GetGenome has supported researchers in Tunisia and Mexico leading to enhanced capacity and the dissemination of novel science to the community. GetGenome has also engaged with training and network building in Zambia and Bangladesh during the reporting period. This work focusses on the surveillance of damaging wheat diseases in the region. ## **Additional details of objectives and activities (Optional information)** You **may choose** to include further statements, where relevant, about: - policy on grantmaking; - policy programme related investment; - contribution made by volunteers. March **2012** **TAR** 3 Section D Achievements and performance **Summary of the main achievements of the charity during the year** Engaged >50 researchers in genomics and open science training in Tunisia, Mexico, Zambia and Bangladesh. Provided support for the awardees-researchers to published 20 pre-print research articles within a GetGenome pre-print community. Built a network of researchers to further enhance their learning and collaboration opportunities. March **2012** **TAR** 4 ## **Section E Financial review** Our charity maintains reserves proportional to operational costs to ensure **Brief statement of the** continuity in times of financial uncertainty. These funds are safeguarded **charity’s policy on reserves** to support essential activities during unforeseen challenges, sustaining our mission and the impact of our programs **Details of any funds materially in deficit** None ## **Further financial review details (Optional information)** You **may choose** to include additional information, where relevant about: - the charity’s principal sources of funds (including any fundraising); - how expenditure has supported the key objectives of the charity; - investment policy and objectives including any ethical investment policy adopted. ## **Section F Other optional information** ## **Section G Declaration** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Sophien Kamoun FRS **Position (eg Secretary, Chair,** Trustee, co-founder **etc) Date** November 14th, 2024 March **2012** **TAR** 5 **Charity Name No (if any) GetGenome 1201069 Receipts and payments accounts For the period** Period start date Period end date **To from** 18/11/2022 31/03/2024 ## **Section A Receipts and payments** |**A1 Receipts**|**Unrestricted**
**funds**
**to the nearest £**|**Unrestricted**
**funds**
**to the nearest £**|**Restricted funds**
**to the nearest £**|**Restricted funds**
**to the nearest £**|**Endowment**
**funds**
**to the nearest £**|**Endowment**
**funds**
**to the nearest £**|**Total funds**
**to the nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**| |---|---|---|---|---|---|---|---| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| |**_Sub total_**_(Gross income for AR)_|**-**||**-**||**-**||**-**| ||||||||| |**A2 Asset and investment sales,**
**(see table).**|||||||| ||**-**||||||| ||**-**||||||| |**_Sub total_**|**-**||||||| |**_Total receipts_**
**A3 Payments**|||||||| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| ||**-**||**-**||**-**||**-**| |**_Sub total_ **|**-**||**-**||**-**||**-**| ||||||||| |**A4 Asset and investment**
**purchases, (see table)**|||||||| ||**-**||||||| ||**-**||||||| |**_Sub total_ **|**-**||||||| |**_Total payments_**
**_Net of receipts/(payments)_**
**A5 Transfers between funds**
**A6 Cash funds last year end**
**_Cash funds this year end_**|||||||| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| ||**-**||||||**-**| CCXX R1 accounts (SS) 14/11/2024 1 ## **Section B Statement of assets and liabilities at the end of the period** |**Categories**
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|**Details**
**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments account(s))
**Details**|**Unrestricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Unrestricted**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which asset**
**belongs**
**Fund to which asset**
**belongs**
**Fund to which**
**liability relates**|**Restricted funds**
**to nearest £**| |---|---|---|---| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||OK| ||||**Restricted funds**
**to nearest £**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Cost (optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Cost (optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**Amount due**
**(optional)**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| ||||**-**| Signed by one or two trustees on behalf of all the trustees ## Signature Print Name Sophien Kamoun FRS CCXX R2 accounts (SS) 14/11/2024 2 **----- Start of picture text -----**
CC16a
**----- End of picture text -----**
**----- Start of picture text -----**
Last year
**----- End of picture text -----**
**to the nearest £ - - - - - - - - -** **-** **-** **-** CCXX R3 accounts (SS) 14/11/2024 3 **----- Start of picture text -----**
Endowment
funds
to nearest £
**----- End of picture text -----**
**-** OK **Endowment funds to nearest £** **-** **Current value (optional)** **-** **Current value (optional)** **-** **When due (optional)** ## Date of approval 14/11/2024 CCXX R4 accounts (SS) 14/11/2024 4